TheraRadar
← Back
Data updated: Mar 29, 2026

TARO PHARM INDS

NeurologyCardiovascularDermatology
Generics

TARO PHARM INDS is a generic drug manufacturer focused on Neurology, Cardiovascular, Dermatology.

1998
Since
11
Drugs
-
Trials
121
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-30
Labeling
LAMOTRIGINE 2026-01-08
FLUCONAZOLE 2026-01-08
CARBAMAZEPINE 2026-01-05
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 40%
2 drugs
Cardiovascular 20%
1 drugs
Dermatology 20%
1 drugs
Immunology 20%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

PAI HOLDINGS PHARM big-pharma
Dermatology, Neurology, Cardiovascular, Immunology
Eli Lilly big-pharma
Immunology, Neurology, Dermatology
BAUSCH specialty
Dermatology, Immunology, Cardiovascular
ADVANZ PHARMA big-pharma
Immunology, Neurology, Cardiovascular, Dermatology
COSETTE other
Cardiovascular, Dermatology, Immunology